Synopsis
Synopsis
0
JDMF
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Aequamen
2. Betahistin Al
3. Betahistin Ratiopharm
4. Betahistin Stada
5. Betahistin-ratiopharm
6. Betahistine
7. Betahistine Biphar
8. Betahistine Dihydrobromide
9. Betahistine Hydrochloride
10. Betahistine Mesylate
11. Betahistine Methanesulfonate
12. Betahistine Methanesulphonate
13. Betaserc
14. Betavert
15. By Vertin
16. By-vertin
17. Dihydrobromide, Betahistine
18. Dihydrochloride, Betahistine
19. Extovyl
20. Fidium
21. Hydrochloride, Betahistine
22. Lectil
23. Melopat
24. Mersilon
25. Mesylate, Betahistine
26. Methanesulfonate, Betahistine
27. Methanesulphonate, Betahistine
28. Pt 9
29. Pt-9
30. Pt9
31. Ribrain
32. Serc
33. Vasomotal
34. Vertigon
1. 5579-84-0
2. Betahistine Hydrochloride
3. Betahistine 2hcl
4. Betahistine Hcl
5. Serc
6. Betaserc
7. Microser
8. Antivom
9. 2-pyridineethanamine, N-methyl-, Dihydrochloride
10. Betahistine (dihydrochloride)
11. Pt-9
12. 2-(2-(methylamino)ethyl)pyridine Dihydrochloride
13. Betahistine Hydrochloride [usan:usp]
14. Beta-histine Dihdrochloride
15. N-methyl-n-(2-pyridin-2-ylethyl)amine Dihydrochloride
16. 5579-84-0 (hcl)
17. 49k58smz7u
18. Methyl[2-(2-pyridyl)ethyl]amine Dihydrochloride
19. N-methyl-2-pyridin-2-ylethanamine;dihydrochloride
20. Veserc
21. Mfcd00012813
22. N-methyl-2-(pyridin-2-yl)ethanamine Dihydrochloride
23. Nsc-757397
24. Methyl[2-(pyridin-2-yl)ethyl]amine Dihydrochloride
25. Novo-betahistine
26. Pt 9
27. Betahistine Hydrochloride [usan]
28. Einecs 226-966-5
29. Unii-49k58smz7u
30. Betahistine Dihcl
31. Betahistine Di Hcl
32. Serc (tn)
33. Beta-histine Dihydrochloride
34. N-methyl-2-pyridin-2-ylethanamine Dihydrochloride
35. Schembl60646
36. Spectrum1500670
37. Betahistine Hydrochloride ,(s)
38. Betahistine Hydrochloride (usp)
39. Chembl1446813
40. Hy-b0524a
41. Betahistine Dihydrochloride, 97%
42. Dtxsid10204355
43. Amy40800
44. Bcp13779
45. Ccg-40327
46. S3176
47. Akos015891507
48. Ks-5298
49. Nsc 757397
50. 2-(2-(methylamino)ethyl)pyridine 2hcl
51. Betahistine Dihydrochloride [mi]
52. Betahistine Hydrochloride [mart.]
53. Betahistine Hydrochloride [vandf]
54. Ncgc00095910-01
55. Betahistine Hydrochloride [usp-rs]
56. Betahistine Hydrochloride [who-dd]
57. Db-052800
58. Ft-0622911
59. Ft-0663076
60. Sw196969-3
61. En300-31560
62. 79b840
63. D03102
64. Betahistine Hydrochloride [usp Monograph]
65. A830811
66. Betahistine Dihydrochloride [ep Monograph]
67. N-methyl-2-(2-pyridinyl)ethanamine Dihydrochloride
68. N-methyl-2-(pyridin-2-yl)ethanaminedihydrochloride
69. N-methyl-2-pyridin-2-yl-ethanamine Dihydrochloride
70. Q27259291
71. Betahistine Dihydrochloride, European Pharmacopoeia (ep) Reference Standard
72. Betahistine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
| Molecular Weight | 209.11 g/mol |
|---|---|
| Molecular Formula | C8H14Cl2N2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 208.0534038 g/mol |
| Monoisotopic Mass | 208.0534038 g/mol |
| Topological Polar Surface Area | 24.9 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 83.3 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Histamine Agonists
Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Certificate Number : CEP 2009-177 - Rev 03
Issue Date : 2024-12-23
Type : Chemical
Substance Number : 1665
Status : Valid
Registrant Name : Sam-O Pharmaceutical Co., Ltd.
Registration Date : 2024-11-12
Registration Number : 20220916-211-J-1364(A)
Manufacturer Name : LABORATORIOS ESPINOS Y BOFILL SA (LEBSA)
Manufacturer Address : Ctra. De L'Hospitalet, 34 08940 Cornellà De Llobregat, Barcelona, Spain
| Available Reg Filing : ASMF |
BioXera Pharma: A trusted partner for high-quality human and veterinary APIs and intermediates across global regulated markets.
Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : CEP 2013-240 - Rev 02
Issue Date : 2024-07-09
Type : Chemical
Substance Number : 1665
Status : Valid
Date of Issue : 2025-09-18
Valid Till : 2028-07-02
Written Confirmation Number : WC-0195
Address of the Firm :
| Available Reg Filing : CA, CN, RU |
Certificate Number : CEP 2011-101 - Rev 04
Issue Date : 2024-07-31
Type : Chemical
Substance Number : 1665
Status : Valid
Date of Issue : 2025-08-05
Valid Till : 2028-06-25
Written Confirmation Number : WC-0054
Address of the Firm :
Registrant Name : Medipoem Co., Ltd.
Registration Date : 2025-03-14
Registration Number : 20250205-211-J-1756(1)
Manufacturer Name : Ami Lifesciences Private Limited
Manufacturer Address : Block No. 82/B, ECP Road At & Post. Karakhadi, Tal-Padra, City : Karakhadi-391450, Dist : Vadodara, Gujarat State, India
| Available Reg Filing : BR, MX |
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
Hebei AiYoung Pharmaceutical Technology delivering high-quality APIs, intermediates, and end-to-end pharma solutions globally.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19593
Submission : 2006-06-23
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36103
Submission : 2021-07-14
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19495
Submission : 2006-06-05
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Certificate Number : CEP 2009-177 - Rev 03
Status : Valid
Issue Date : 2024-12-23
Type : Chemical
Substance Number : 1665
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : CEP 2013-240 - Rev 02
Status : Valid
Issue Date : 2024-07-09
Type : Chemical
Substance Number : 1665
Certificate Number : CEP 2011-101 - Rev 04
Status : Valid
Issue Date : 2024-07-31
Type : Chemical
Substance Number : 1665
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2012-058 - Rev 01
Status : Valid
Issue Date : 2023-11-16
Type : Chemical
Substance Number : 1665

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2009-001 - Rev 03
Status : Valid
Issue Date : 2025-10-28
Type : Chemical
Substance Number : 1665

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2022-505 - Rev 02
Status : Valid
Issue Date : 2025-09-30
Type : Chemical
Substance Number : 1665

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2006-316 - Rev 05
Status : Valid
Issue Date : 2024-07-08
Type : Chemical
Substance Number : 1665

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Betahistine Dihydrochloride EP/BP
Date of Issue : 2025-09-18
Valid Till : 2028-07-02
Written Confirmation Number : WC-0195
Address of the Firm : Plot No. 3102/B, GIDC Estate Ankleshwar, Bharuch-393002, Gujarat, India
Betahistine Dihydrochloride Ph.Eur.
Date of Issue : 2025-08-05
Valid Till : 2028-06-25
Written Confirmation Number : WC-0054
Address of the Firm : Block No. 82/B, ECP Road, At & Post Karakhadi, Tal - Padra, Dist. Baroda, Gujara...
Betahistine Dihydrochloride EP
Date of Issue : 2025-08-08
Valid Till : 2028-06-10
Written Confirmation Number : WC-0017
Address of the Firm : Unit-II, SurveyNo.:10&13,Gaddapotharam (Village), IDA-Kazipally, Jinnaram (Manda...

Date of Issue : 2025-10-08
Valid Till : 2028-06-26
Written Confirmation Number : WC-0016
Address of the Firm : (Unit-9) Plot No.5, Road No. 12, Jawaharlal Nehru Pharma City, Tadi Village, Par...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Registrant Name : Sam-O Pharmaceutical Co., Ltd.
Registration Date : 2024-11-12
Registration Number : 20220916-211-J-1364(A)
Manufacturer Name : LABORATORIOS ESPINOS Y BOFIL...
Manufacturer Address : Ctra. De L'Hospitalet, 34 08940 Cornellà De Llobregat, Barcelona, Spain
Registrant Name : G-Max Pharmachem Co., Ltd.
Registration Date : 2022-09-16
Registration Number : 20220916-211-J-1364
Manufacturer Name : LABORATORIOS ESPINOS Y BOFIL...
Manufacturer Address : Ctra. De L'Hospitalet, 34 08940 Cornellà De Llobregat, Barcelona, Spain
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2025-02-05
Registration Number : 20250205-211-J-1756
Manufacturer Name : Ami Lifesciences Private Lim...
Manufacturer Address : Block No. 82/B, ECP Road At & Post. Karakhadi, Tal-Padra, City : Karakhadi-391450, Di...
Registrant Name : Medipoem Co., Ltd.
Registration Date : 2025-03-14
Registration Number : 20250205-211-J-1756(1)
Manufacturer Name : Ami Lifesciences Private Lim...
Manufacturer Address : Block No. 82/B, ECP Road At & Post. Karakhadi, Tal-Padra, City : Karakhadi-391450, Di...
Registrant Name : Sam-O Pharmaceutical Co., Ltd.
Registration Date : 2025-08-25
Registration Number : 20250825-211-J-2002
Manufacturer Name : Olon SPA
Manufacturer Address : Via Livelli 1, Casaletto Lodigiano, 26852, Italy

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]About the Company : Lebsa is an innovative European lab specializing in niche API synthesis, manufacture, and commercialization. With 70 years of experience, it is a reputable global player in generic...
About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...
BioXera Pharma: A trusted partner for high-quality human and veterinary APIs and intermediates across global regulated markets.
About the Company : BioXera Pharma is a quality-focused manufacturer of APIs, veterinary APIs, and intermediates, with expertise in innovative process development for domestic and regulated internatio...
Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.
About the Company : Synnat Pharma is a fast-growing pharmaceutical company focused on the development, identification, production, and distribution of phytochemicals and botanical extracts. Its APIs a...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
About the Company : Cohance Lifesciences is a leading CDMO and API platform delivering products and services across the full molecule lifecycle, from development to commercialization. With strong expe...
About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...
About the Company : Ami Lifesciences, established in 2006, is a rapidly growing API manufacturing company in India with strong capabilities in cardiovascular, anti-diabetic, CNS, and respiratory thera...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
Hebei AiYoung Pharmaceutical Technology delivering high-quality APIs, intermediates, and end-to-end pharma solutions globally.
About the Company : Hebei AiYoung Pharmaceutical Group is an integrated pharmaceutical company engaged in the production, research, and sale of chemical medicines, APIs, intermediates, and finished fo...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Dosage Form :
Dosage Strength : 50 Cpr 8 Mg
Price Per Pack (Euro) : 9.5
Published in :
Country : Italy
RX/OTC/DISCN : Class C

Dosage Form :
Dosage Strength : 20 Cpr 16 Mg
Price Per Pack (Euro) : 7.5
Published in :
Country : Italy
RX/OTC/DISCN : Class C

Dosage Form :
Dosage Strength : 30 Cpr 16 Mg
Price Per Pack (Euro) : 11.25
Published in :
Country : Italy
RX/OTC/DISCN : Class C

ANGENERICO SpA
Dosage Form :
Dosage Strength : 50 Cpr 8 Mg
Price Per Pack (Euro) : 9.5
Published in :
Country : Italy
RX/OTC/DISCN : Class C

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANGENERICO SpA
Dosage Form :
Dosage Strength : 20 Cpr 16 Mg
Price Per Pack (Euro) : 7.5
Published in :
Country : Italy
RX/OTC/DISCN : Class C

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
BB FARMA Srl
Dosage Form :
Dosage Strength : 20 Cpr 16 Mg
Price Per Pack (Euro) : 7.69
Published in :
Country : Italy
RX/OTC/DISCN : Class C

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
C.T. LAB.FARMACEUTICO Srl
Dosage Form :
Dosage Strength : 50 Cpr 8 Mg
Price Per Pack (Euro) : 11.22
Published in :
Country : Italy
RX/OTC/DISCN : Class C

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
C.T. LAB.FARMACEUTICO Srl
Dosage Form :
Dosage Strength : 20 Cpr 16 Mg
Price Per Pack (Euro) : 9.18
Published in :
Country : Italy
RX/OTC/DISCN : Class C

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
PRODOTTI FORMENTI Srl
Dosage Form :
Dosage Strength : 50 Cpr 8 Mg
Price Per Pack (Euro) : 11.95
Published in :
Country : Italy
RX/OTC/DISCN : Class C

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
PRODOTTI FORMENTI Srl
Dosage Form :
Dosage Strength : 30 Cpr 16 Mg
Price Per Pack (Euro) : 13.5
Published in :
Country : Italy
RX/OTC/DISCN : Class C

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Reply
26 Feb 2026
Reply
23 Feb 2026
Reply
28 Apr 2025
Reply
13 Dec 2024
Reply
03 Dec 2024
Reply
13 Jun 2024
Reply
06 Apr 2024
Reply
14 Dec 2023
Reply
21 Sep 2023
Reply
09 May 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
86
PharmaCompass offers a list of Betahistine Dihydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Betahistine Dihydrochloride manufacturer or Betahistine Dihydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Betahistine Dihydrochloride manufacturer or Betahistine Dihydrochloride supplier.
A Betahistine hydrochloride (USP) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Betahistine hydrochloride (USP), including repackagers and relabelers. The FDA regulates Betahistine hydrochloride (USP) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Betahistine hydrochloride (USP) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Betahistine hydrochloride (USP) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Betahistine hydrochloride (USP) supplier is an individual or a company that provides Betahistine hydrochloride (USP) active pharmaceutical ingredient (API) or Betahistine hydrochloride (USP) finished formulations upon request. The Betahistine hydrochloride (USP) suppliers may include Betahistine hydrochloride (USP) API manufacturers, exporters, distributors and traders.
click here to find a list of Betahistine hydrochloride (USP) suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Betahistine hydrochloride (USP) DMF (Drug Master File) is a document detailing the whole manufacturing process of Betahistine hydrochloride (USP) active pharmaceutical ingredient (API) in detail. Different forms of Betahistine hydrochloride (USP) DMFs exist exist since differing nations have different regulations, such as Betahistine hydrochloride (USP) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Betahistine hydrochloride (USP) DMF submitted to regulatory agencies in the US is known as a USDMF. Betahistine hydrochloride (USP) USDMF includes data on Betahistine hydrochloride (USP)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Betahistine hydrochloride (USP) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Betahistine hydrochloride (USP) suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Betahistine hydrochloride (USP) Drug Master File in Korea (Betahistine hydrochloride (USP) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Betahistine hydrochloride (USP). The MFDS reviews the Betahistine hydrochloride (USP) KDMF as part of the drug registration process and uses the information provided in the Betahistine hydrochloride (USP) KDMF to evaluate the safety and efficacy of the drug.
After submitting a Betahistine hydrochloride (USP) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Betahistine hydrochloride (USP) API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Betahistine hydrochloride (USP) suppliers with KDMF on PharmaCompass.
A Betahistine hydrochloride (USP) CEP of the European Pharmacopoeia monograph is often referred to as a Betahistine hydrochloride (USP) Certificate of Suitability (COS). The purpose of a Betahistine hydrochloride (USP) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Betahistine hydrochloride (USP) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Betahistine hydrochloride (USP) to their clients by showing that a Betahistine hydrochloride (USP) CEP has been issued for it. The manufacturer submits a Betahistine hydrochloride (USP) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Betahistine hydrochloride (USP) CEP holder for the record. Additionally, the data presented in the Betahistine hydrochloride (USP) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Betahistine hydrochloride (USP) DMF.
A Betahistine hydrochloride (USP) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Betahistine hydrochloride (USP) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Betahistine hydrochloride (USP) suppliers with CEP (COS) on PharmaCompass.
A Betahistine hydrochloride (USP) written confirmation (Betahistine hydrochloride (USP) WC) is an official document issued by a regulatory agency to a Betahistine hydrochloride (USP) manufacturer, verifying that the manufacturing facility of a Betahistine hydrochloride (USP) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Betahistine hydrochloride (USP) APIs or Betahistine hydrochloride (USP) finished pharmaceutical products to another nation, regulatory agencies frequently require a Betahistine hydrochloride (USP) WC (written confirmation) as part of the regulatory process.
click here to find a list of Betahistine hydrochloride (USP) suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Betahistine hydrochloride (USP) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Betahistine hydrochloride (USP) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Betahistine hydrochloride (USP) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Betahistine hydrochloride (USP) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Betahistine hydrochloride (USP) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Betahistine hydrochloride (USP) suppliers with NDC on PharmaCompass.
Betahistine hydrochloride (USP) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Betahistine hydrochloride (USP) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Betahistine hydrochloride (USP) GMP manufacturer or Betahistine hydrochloride (USP) GMP API supplier for your needs.
A Betahistine hydrochloride (USP) CoA (Certificate of Analysis) is a formal document that attests to Betahistine hydrochloride (USP)'s compliance with Betahistine hydrochloride (USP) specifications and serves as a tool for batch-level quality control.
Betahistine hydrochloride (USP) CoA mostly includes findings from lab analyses of a specific batch. For each Betahistine hydrochloride (USP) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Betahistine hydrochloride (USP) may be tested according to a variety of international standards, such as European Pharmacopoeia (Betahistine hydrochloride (USP) EP), Betahistine hydrochloride (USP) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Betahistine hydrochloride (USP) USP).